Clicky

TTY Biopharm Co Ltd(4105)

Description: TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, Veiasu, and Pemazyre names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. The company was founded in 1960 and is headquartered in Taipei, Taiwan.


Keywords: Life Sciences Molecular Biology Osteoporosis Biopharm Daptomycin Yondelis

Home Page: eng.tty.com.tw

No.3-1, Park Street
Taipei, 11503
Taiwan
Phone: 886 2 2652 5999


Officers

Name Title
Mr. Kuo-Chiang Chang CFO, Corp. Governance Officer & Sr. Assistant VP of Financial Division
Ms. Shu-Wen Wang Accounting Officer
Ms. Shu-Fen Huang Chief Legal & Compliance Officer
Wei-Ying Yin Director of Public Affairs Department
Mr. Jen-Yang Chang Chief Human Resource Officer
Ms. Si-Yuan Yang Sr. VP
Mr. Allen Chu Head of Intensive Care Bus. Unit
Ms. Ching-Lan Hou Gen. Mang.
Yung-Min Chiang Internal Audit Officer

Exchange: TWO

Country: TW : Taiwan

Currency: New Taiwan Dollar (NT$)

Forward PE: 16.7785
Trailing PE: 16.5336
Price-to-Book MRQ: 3.7773
Price-to-Sales TTM: 4.1
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks